BLS Pharmaceuticals Limited
BLS Pharmaceuticals Limited
- P/E ratio
- 24.23
Your view on BLS.AX
Overview
What the company does, where it operates, and who runs it.
About BLS Pharmaceuticals Limited
- Industry
- Specialty Business Services
- Sector
- Industrials
- CEO
- Sam Watson
- Headquarters
- Level 5, Sydney, NSW, AU
- Industry
- Specialty Business Services
- Sector
- Industrials
- CEO
- Sam Watson
- Headquarters
- Level 5, Sydney, NSW, AU
BLS Pharmaceuticals Ltd. engages in the research, development, market and distribution of health products. It operates through the following segments: Wholesale, Plant Based, and Direct Sales. The Wholesale segment covers operation in United States of America (USA), and Asia.
The Plant Based segment includes manufacturing, commercialization, and distribution of plant-based products. The Direct Sales segment focuses on Australia, and Asia operation. The company was founded in 1998 and is headquartered in Sydney, Australia.
Stock Data
Price chart, volume, and trading data.
Financial Ratios
Profitability, returns, valuation, and leverage ratios.
About this section
Valuation, profitability, liquidity and leverage ratios for BLS Pharmaceuticals Limited. Starting points for BLS Pharmaceuticals Limited: P/E 24.2, EPS AUD 0.04, beta 0.62 — an Specialty Business Services name. P/E, P/B, EV/EBITDA, margins, return on equity, current ratio and debt coverage, each shown against the company's own history.
Dividend Analysis
Yield, payout ratio, and dividend coverage metrics.
About this section
Dividend history, yield and payout sustainability for BLS Pharmaceuticals Limited. BLS Pharmaceuticals Limited does not currently pay a regular dividend, so this section tracks capacity rather than history. Per-share payments, yield over time, payout ratio and growth streak, with coverage measured against free cash flow.
Earnings Analysis
EPS history, beat rate, and upcoming earnings reports.
About this section
Reported vs. expected earnings history for BLS Pharmaceuticals Limited. Trailing twelve-month EPS for BLS Pharmaceuticals Limited stands at AUD 0.04. EPS surprises by quarter, revenue against estimates, and the upcoming reporting date.
Financial Statements
Income statement, balance sheet, and cash flow statements.
About this section
Income statement, balance sheet and cash flow history for BLS Pharmaceuticals Limited. BLS Pharmaceuticals Limited has reported as a listed company since 2000. Annual and quarterly filings with period-over-period comparison, so you can trace how revenue, margins and cash generation have moved.
Comparables
List of peer companies in the same industry.
| Ticker | Type | Company | Sector | Industry | |
|---|---|---|---|---|---|
| BIO.AXBiome Australia Limited | Healthcare | Medical - Pharmaceuticals | — | ||
| BP8.AXBPH Global Ltd | Healthcare | Drug Manufacturers - Specialty & Generic | — | ||
| CSL.AXCSL Limited | Healthcare | Biotechnology | — | ||
| ECS.AXECS Botanics Holdings Ltd | Healthcare | Drug Manufacturers - Specialty & Generic | — | ||
| EXL.AXElixinol Wellness Limited | Healthcare | Drug Manufacturers - Specialty & Generic | — | ||
| LGP.AXLittle Green Pharma Ltd | Healthcare | Drug Manufacturers - Specialty & Generic | — | ||
| MYX.AXMayne Pharma Group Limited | Healthcare | Medical - Pharmaceuticals | — | ||
| S66.AXStar Combo Pharma Limited | Consumer Defensive | Household & Personal Products | — | ||
| Ticker | Type | Company | Sector | Exchange | Mkt cap |
|---|---|---|---|---|---|
| CSGUConsolidated Sports Media Group | Industrials | OTC | — | ||
| CTAGFCapita plc | Industrials | OTC | $437.9M | ||
| CTAGYCapita plc | Industrials | OTC | $7.2B | ||
| CTASCintas Corporation | Industrials | NASDAQ | $88.2B | ||
| CTGLCitrine Global Corp. | Industrials | OTC | $151.3M | ||
| CUP.AXCount Limited | Industrials | ASX | — | ||
| CVEOCiveo Corporation | Industrials | NYSE | $355.2M | ||
| CWPSConwest Associates, LP | Industrials | OTC | — | ||
| DCM.TODATA Communications Management Corp. | Industrials | TSX | $160.2M | ||
| DCMDFDATA Communications Management Corp. | Industrials | OTC | $58.9M | ||
| DIV.TODiversified Royalty Corp. | Industrials | TSX | $600.9M | ||
| DLHCDLH Holdings Corp. | Industrials | NASDAQ | $41.3M | ||
Comments
Comments and replies from FRC members about this company.
No comments yet
Be the first to ask a question or say what you make of BLS Pharmaceuticals Limited.